Switch to:

Ratios

vs
industry
vs
history
P/E(ttm) 20.21
XPH's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 20.21 )
Ranked among companies with meaningful P/E(ttm) only.
XPH' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 31.71
Current: 20.21
0
31.71
PE(NRI) 20.21
XPH's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 20.21 )
Ranked among companies with meaningful PE(NRI) only.
XPH' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 31.71
Current: 20.21
0
31.71
P/B 2.24
XPH's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 2.24 )
Ranked among companies with meaningful P/B only.
XPH' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.79
Current: 2.24
0
2.79

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.62
XPH's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 0.62 )
Ranked among companies with meaningful Dividend Yield only.
XPH' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.66
Current: 0.62
0
0.66
Yield on cost (5-Year) 0.62
XPH's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 0.62 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
XPH' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.66
Current: 0.62
0
0.66

More Statistics

Short Percentage of Float0.00%
52-Week Range $36.67 - 47.65
Shares Outstanding (Mil)11,050,270.00
» More Articles for XPH

Headlines

Articles On GuruFocus.com
How Fast Can a Big Bank Grow Its Deposits? Feb 18 2017 
Stocks That Are Reaching Their 3-Year Lows Feb 18 2017 
3M Company Hikes Dividend by 6% but Trades at an Elevated Valuation Feb 18 2017 
Weekly Top Insider Buys Highlight for the Week of Feb. 17 Feb 18 2017 
Will Mid-Sized Cities Rally the US Housing Market in 2017? Feb 18 2017 
Dow Jones and Nasdaq Reach New Highs on Friday Feb 17 2017 
Prem Watsa Ends Period of Shorting Market With $1.2 Billion Loss Feb 17 2017 
How Much Will Genesis Energy Raise Distributions in 2017? Feb 17 2017 
Which Dividend Achiever Utility Is Better – Dominion or PPL? Feb 17 2017 
Reasons to Own This MLP for the Long Term Feb 17 2017 

More From Other Websites
Drug stocks dip after Spicer affirms Trump’s stance on cutting costs Feb 07 2017
Q4 Earnings Faring Well for Pharma ETFs Feb 06 2017
What to Expect from Eli Lilly’s Cardiovascular Franchise in 4Q16 Jan 26 2017
A.M. Funds Roundup: Investors Buy Volatility ETFs, Exit Equity ETFs Ahead Of Inauguration, Jan 20 2017
What Lies Ahead for Pharma ETFs? Jan 19 2017
Biotech ETFs: When Will The Pain End? Jan 17 2017
Biotech ETFs Continue To Bleed Jan 12 2017
Trump's First Press Conference Puts These ETFs in Focus Jan 12 2017
Mylan’s Specialty Segment: The Effect of Falling EpiPen Sales Jan 12 2017
The Biggest Loser: Endo International Tumbles 8.6% Jan 11 2017
2 Stocks For a Trump-ed Up Pharma Market Jan 11 2017
Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" Jan 11 2017
Tesaro NDA for ovarian cancer treatment granted priority review Dec 20 2016
It Was a Successful 3Q16 for Horizon Pharma’s Primary Care Dec 20 2016
Mylan's first generic EpiPen launches at less than half the cost of branded version Dec 16 2016
Loss of Patent Protection to Drag Pfizer’s Top Line Dec 14 2016
Ibrance Is the Only Registered CDK 4/6 Inhibitor for Breast Cancer Dec 12 2016
Express Scripts’ stock rocked by tweets from short seller Andrew Left Dec 09 2016
Biotech & Pharma ETFs to Suffer in 2017 Too? Dec 08 2016
Express Scripts' stock dives after short seller Andrew Left takes aim Dec 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK